1,959 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 885 increasing their positions, 762 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 1,9881,959 (-29)

5% less capital invested

Capital invested by funds: $152B → $144B (-$8.2B)

18% less funds holding in top 10

Funds holding in top 10: 286234 (-52)

Holders
1,959
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
234
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.25B
Puts
$2.33B
Net Calls
Net Calls Change

Top Buyers

1 +$351M
2 +$340M
3 +$281M
4
Renaissance Technologies
Renaissance Technologies
New York
+$240M
5
JP Morgan Chase
JP Morgan Chase
New York
+$183M
Name Holding Trade Value Shares
Change
Change in
Stake
1051
$2.49M
1052
$2.47M
1053
$2.46M
1054
$2.45M
1055
$2.45M
1056
$2.44M
1057
$2.44M
1058
$2.44M
1059
$2.43M
1060
$2.43M
1061
$2.42M
1062
$2.41M
1063
$2.39M
1064
$2.39M
1065
$2.39M
1066
$2.38M
1067
$2.38M
1068
$2.37M
1069
$2.37M
1070
$2.36M
1071
$2.36M
1072
$2.35M
1073
$2.35M
1074
$2.32M
1075
$2.32M